Endocrine oncology

Representation and Bias in Artificial Intelligence Models for Thyroid Cancer: A Systematic Review

ThyroidPublished Systematic review

Authors' conclusion

The findings highlight significant gaps in the diversity and representativeness of data used in thyroid cancer AI models. Current models align with epidemiological trends but lack comprehensive demographic inclusion.

Study context

Population
Studies of AI models for thyroid cancer management providing demographic details; EMBASE, PubMed and Google Scholar up to January 2024
Participants
197 studies
Outcome
Demographic representation in thyroid cancer AI model studies
Methodological detailsPRISMA-reported, Cochrane handbook, two independent reviewers
  • PRISMA-reported
  • Cochrane handbook
  • Two independent reviewers

Pooled result

As reported in the abstract

Studies focusing on diagnosis
133
Studies focusing on prediction/prognosis
47
Studies with participants from China
124
Studies with participants from the US
26
Female participants
12,410
Male participants
4222
East Asians (underrepresented; global thyroid cancer prevalence 18.7%)
14.6%
White participants (overrepresented; global prevalence 20.7%)
26.8%
Black participants (overrepresented; global prevalence 11.3%)
26.8%

Original publication

Representation and Bias in Artificial Intelligence Models for Thyroid Cancer: A Systematic Review. Thyroid. Published 28 August 2025. doi:10.1177/10507256251372175

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.